Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery

NCT00626015 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasms of Brain

Interventions

BIOLOGICAL: PEP-3-KLH conjugate vaccine
BIOLOGICAL: daclizumab
DRUG: temozolomide
OTHER: placebo
BIOLOGICAL: PEP-3-KLH

Sponsor

John Sampson

Collaborators

[object Object]